Immunotherapy and cell therapy have emerged as the two most promising trends in global cancer treatment, with an annual market growth rate exceeding 20%. The ability to accurately select effective cells, maintain their activity, and rapidly expand is our advantage, enabling us to gain technological dominance in this competition.